Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minna Holm

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The American Journal of Psychiatry|October 6, 2022
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective PsychosisMarco Solmi, Heidi Taipale, Minna Holm, et al.
Journal of Affective Disorders|December 26, 2021
Antidepressant use among immigrants with depressive disorder living in Finland: A register-based studyValentina Kieseppä, Niina Markkula, Heidi Taipale, et al.
Schizophrenia (Heidelberg, Germany)|February 19, 2024
Enhancing identification of nonaffective psychosis in register-based studiesMinna Holm, Kimmo Suokas, Emmi Liukko, et al.
Schizophrenia (Heidelberg, Germany)|August 4, 2022
Extrapyramidal symptoms predict cognitive performance after first-episode psychosisMaija Lindgren, Sebastian Therman, Anna Avellan, et al.
Psychological Medicine|May 9, 2024
Factors contributing to readmission in patients with psychotic disorders, with a special reference to first follow-up visit in outpatient careKimmo Suokas, Maija Lindgren, Mika Gissler, et al.
Schizophrenia Research|April 5, 2024
Antipsychotic medications and sleep problems in patients with schizophreniaErik Cederlöf, Minna Holm, Heidi Taipale, et al.
Schizophrenia (Heidelberg, Germany)|December 31, 2024
General medical comorbidities in psychotic disorders in the Finnish SUPER studyJohan Ahti, Tuula Kieseppä, Willehard Haaki, et al.
Schizophrenia Research|February 24, 2024
Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophreniaVille Mäkipelto, Annamari Tuulio-Henriksson, Christian Hakulinen, et al.
Schizophrenia Research|May 10, 2022
Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER studyJohan Ahti, Tuula Kieseppä, Jaana Suvisaari, et al.
Acta Neuropsychiatrica|March 25, 2025
Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone usersElina Hietala, Anssi Solismaa, Markku Lähteenvuo, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The American Journal of Psychiatry|October 6, 2022
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective PsychosisMarco Solmi, Heidi Taipale, Minna Holm, et al.
Journal of Affective Disorders|December 26, 2021
Antidepressant use among immigrants with depressive disorder living in Finland: A register-based studyValentina Kieseppä, Niina Markkula, Heidi Taipale, et al.
Schizophrenia (Heidelberg, Germany)|February 19, 2024
Enhancing identification of nonaffective psychosis in register-based studiesMinna Holm, Kimmo Suokas, Emmi Liukko, et al.
Schizophrenia (Heidelberg, Germany)|August 4, 2022
Extrapyramidal symptoms predict cognitive performance after first-episode psychosisMaija Lindgren, Sebastian Therman, Anna Avellan, et al.
Psychological Medicine|May 9, 2024
Factors contributing to readmission in patients with psychotic disorders, with a special reference to first follow-up visit in outpatient careKimmo Suokas, Maija Lindgren, Mika Gissler, et al.
Schizophrenia Research|April 5, 2024
Antipsychotic medications and sleep problems in patients with schizophreniaErik Cederlöf, Minna Holm, Heidi Taipale, et al.
Schizophrenia (Heidelberg, Germany)|December 31, 2024
General medical comorbidities in psychotic disorders in the Finnish SUPER studyJohan Ahti, Tuula Kieseppä, Willehard Haaki, et al.
Schizophrenia Research|February 24, 2024
Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophreniaVille Mäkipelto, Annamari Tuulio-Henriksson, Christian Hakulinen, et al.
Schizophrenia Research|May 10, 2022
Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER studyJohan Ahti, Tuula Kieseppä, Jaana Suvisaari, et al.
Acta Neuropsychiatrica|March 25, 2025
Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone usersElina Hietala, Anssi Solismaa, Markku Lähteenvuo, et al.
Pageof 3